CHGCY Financials
Chugai Pharmaceutical Co Ltd ADR - Financial statements & key metrics
Stock Price
$26.68
Market Cap
$88.57B
P/E Ratio
32.3
EPS
$0.83
Income Statement Highlights
Most Recent Quarter: 2025-12-31
Revenue
$1.32T
Gross Profit
$937.60B
Operating Income
$618.80B
Net Income
$455.05B
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$2.47T
Total Liabilities
$443.16B
Shareholders Equity
$2.03T
Cash & Equivalents
$426.89B
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$408.33B
CapEx
$79.97B
Free Cash Flow
$328.36B
Profitability Metrics
Gross Margin
71.1%
Operating Margin
0.5%
Net Margin
0.3%
ROE
0.2%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is CHGCY revenue?
CHGCY's most recent quarterly revenue was $1.32T. Annual revenue can be calculated by summing the four most recent quarters.
Is CHGCY profitable?
CHGCY reported a profit of $455.05B in the most recent quarter. The net profit margin is 0.3%.
What is CHGCY market cap?
CHGCY has a market capitalization of $88.57B, making it a large-cap stock.
Does CHGCY have debt?
View CHGCY's balance sheet for debt information.
What is CHGCY cash flow?
CHGCY's most recent quarterly free cash flow was $328.36B.